ABSTRACT OBJECTIVES This study investigated the mechanism of lead malfunction by monitoring lead parameters throughout left ventricular assist device (LVAD) implantation.
Twelve-point intraoperative data were collected from a subgroup of 20 patients undergoing LVAD implantation with the axial flow device. Implantation of the axial flow LVAD proceeded as follows: a median sternotomy was performed; a VAD pocket was created in the peritoneal space, and a tunnel to the right rectus was created for the device driveline; cardiopulmonary bypass (CPB) was performed after cannulation of the aorta and right atrium (RA); an LV outflow graft was sewn to the ascending aorta, the LV apex was cored, and the LVAD inflow cannula was attached; CPB was weaned, the pericardium was reconstructed, and the chest was closed. One patient (#27) underwent LVAD implantation with the centrifugal flow LVAD, and standard surgical fashion proceeded as follows: a median sternotomy performed, aorta and RA were cannulated, CPB was implemented, a sewing ring was attached to the LV apex, the apex was cored, the LVAD pump was implanted and secured in the pericardial space, the LV outflow graft was sewn to the ascending aorta, a tunnel to left rectus was created for the driveline, CPB was weaned, the pericardium was reconstructed, and the chest was closed. Hu et al.
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baseline value was considered improved. A pacing threshold that increased by >50% from baseline was considered improved if it returned to #150% of the baseline value. RV pacing lead impedance was considered significantly changed if it increased or decreased by >100 U from the baseline value to the final value at the end of LVAD implantation. HV impedance was considered significantly changed if it increased or decreased by >10 ohm (U) from the baseline vale to the final value at the end of LVAD implantation. These definitions were used to help determine the mechanism of lead malfunction and
were not intended to reflect a change that was necessarily clinically significant.
E l e c t r o c a r d i o g r a p h y a n a l y s i s . The intrinsic QRS interval in sinus rhythm was measured using electrocardiography (ECG) before and after LVAD implantation. QRS measurements were made by computer and confirmed manually. Figure 1 ).
LONG-TERM LEAD OUTCOMES. R V l e a d s e n s i n g . RV leads were tested in 32 patients. RV sensing decreased by more than 50% from baseline in 7 patients (22%) immediately post-LVAD, and RV sensing improved over time in 2 patients (28.6%). RV sensing had improved after 1 week in 1 patient and after 7 weeks in 1 patient ( Table 2 , Figure 1 ).
R V l e a d p a c i n g t h r e s h o l d s . In 2 patients (6.3%), who also had decreased sensing, RV pacing threshold was >50% elevated from baseline immediately postoperatively and was persistently elevated at 1 week (Online Table 1 ). One RV pacing threshold returned to baseline at 3 month (50%).
R V l e a d i m p e d a n c e s . baseline, 41.1 AE 11.2 U at the end of LV implantation (p < 0.0001), 38.9 AE 9.2 U at 1 week (p < 0.0001), and 44.4 AE 9.6 U at 3 to 12 months follow-up (p < 0.0001). None of the 32 leads tested had RV pacing impedances that were out of normal range for the lead before, during, or after LVAD implantation.
None of the 32 leads tested had HV impedances that were out of the expected range for the given lead at any point.
R A l e a d s . Twenty-two RA leads were tested. RA sensing was decreased by more than 50% in 4 patients (18.2%) immediately post-LVAD with RA sensing improved at 1 week in 3 patients (75%).
None of the patients with a decrease of more than 50% in atrial sensing had significant changes in RA pacing threshold, defined as an increase of more than 50% in RA sensing. Sensing during atrial fibrillation or flutter was not compared with sensing during sinus rhythm. Three patients (13.6%) had an increase >50% in RA pacing threshold, 2 of whom (66.7%) had atrial undersensing at 1 week follow-up.
L V l e a d s . LV lead sensing was performed in 10 devices, and threshold testing was performed in 15 leads (Online Table 2 ). Six patients (40%) had increases in threshold, 2 (33.3%) of whom improved over time.
One LV lead had both a decrease of >50% in LV sensing threshold and an increase of >50% in LV had persistently low R waves; in 1 patients (20%), R waves returned to baseline; and 1 patient had died (20%).
We identified 6 patients (18.8%) who had a pacing impedance change >100 U from baseline to final impedance during LVAD implantation, 3 of whom also had >50% decrease in RV lead sensing. Three of these patients had impedance levels tested at serial time points during the surgery. There was no consistent pattern of change in pacing impedance (Online Table 3 ).
We identified 9 patients (28.1%) who had >10-U HV impedance change from baseline to final impedance during LVAD implantation, 2 of whom also had >50% decrease in RV lead sensing. Seven of these patients had HV impedances tested at serial time points during the surgery. All seven patients first had >10-U impedance change detected after weaning from CPB.
( Table 3 , see *). 18.4 to 31.8) (Figure 2) . . One patient improved after 7 weeks (not shown in this figure; serial intraoperative measurements were not performed). Values in bold represent those with >10-U high-voltage impedance change. *The time at which a >10-U impedance change was detected.
Abbreviations as in Table 2 .
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Defibrillator Lead Function During and After LVAD Implantation Electrocardiograms of a patient prior to (A) and after (B) LVAD implantation. The patient had an interventricular conduction delay with a QRS duration of 166 ms prior to LVAD that decreased to 120 ms post-LVAD implantation. is of concern because it may lead to underdetection of tachyarrhythmia and delayed appropriate therapy.
Significant increases in RV pacing threshold have not been consistently observed in previous studies. One study showed a significant increase in RV pacing threshold 6 months after LVAD implantation (2). In 6% of our patients, RV pacing threshold increased by more than 50%.
POSSIBLE MECHANISMS OF ICD LEAD PARAMETER
CHANGE. Although proposed in previous reports, mechanical disruption of the leads during surgery did not explain our findings. We found no radiographic changes in positions of the leads before and after VAD implantation ( Figure 3 ). There was no gross radiographic dislodgement observed in any RA, RV, or LV leads by a blinded radiologist comparing pre-and post-LVAD chest radiographs.
Although bowing was observed in 31% of RV leads, this finding did not occur significantly more often in leads that had >50% reduction in R wave sensing. If frank lead dislodgement were the mechanism of dysfunction, newly placed leads would potentially be more at risk for dysfunction than long-term leads. In fact, RV leads with a decrease of >50% in sensing threshold were implanted for a mean 88 months, longer than the leads with no significant decrease in sensing threshold, mean 30 months.
By prospectively recording ICD lead parameters frequently throughout and following VAD implantation, we localized the time of RV lead sensing changes to after weaning the patients from CPB.
Interestingly, all patients who had a change of >10-U HV impedance also had the change first detected after weaning from CPB. We hypothesize that ICD lead parameter changes following LVAD are due to unloading of the LV and concomitant leftward shifting of the septum, altering the ICD lead/ myocardium conformation. However, due to the small number of patients in the study, the mechanism cannot be determined definitively. Myocardial edema and ischemia associated with CPB could contribute to the altered lead properties. CPB induces a well-described systemic inflammatory response that can lead to multiorgan system failure (5) . The inflammatory response is due to surgical trauma, activation of blood components in the extracorporeal circuit, ischemia and reperfusion injury, and endotoxin release (6) . Inflammatory markers are increased as early as 1 hour after initiation of CPB (7). ICD lead parameter changes related to systemic inflammation have not been described in published reports.
We identified a higher prevalence of reduced GFR, Hu et al.
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